Arterial hypertension and cognitive decline;Hypertension arterielle et declin cognitif

Revue Neurologique

Volumn 155, Issue 9, 1999, Pages 743-748

  Leys, D ^a,c   Pasquier, F ^a,b  

^a Service de Neurologie et Pathologie Neurovasculaire   (France)

^b Service de Neurologie et Centre de la Mémoire   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; NEUROPROTECTIVE AGENT; NITRENDIPINE;

ADULT; AGED; ALZHEIMER DISEASE; BLOOD PRESSURE REGULATION; COGNITION; CONFERENCE PAPER; DEMENTIA; ELDERLY CARE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; NEUROPROTECTION; RISK FACTOR; STROKE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; HYPOTENSION; PSYCHOLOGICAL ASPECT; REVIEW;

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; COGNITION DISORDERS; DEMENTIA; HUMANS; HYPERTENSION; HYPOTENSION; RISK FACTORS;

EID: 0032850469     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. BLOTS ML, HOES AW, KOUDSTAAL PJ, HOFMAN A, GROBBEE DE. (1996). Common carotid intimamedia thickness predicts stroke in the Rotterdam study. J Neural, 243: 6.
2. BONDAREFF W, MouNTJOY CQ, ROTH M. (1982). Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology, 32:164-168.
3. BREITNER JCS, WELSH K, GAU BA, MCDONALD WM, STEFFENS DC, SAUNDERS AM, MAGRUDER KM, HELMS MJ, PLASSMAN BL, FOLSTEIN MF, BRANDT J, ROBINETTE CD, PAGE WF. (1995). Alzheimer's disease in the National Academy of Sciences -National Research Council Registry of Aging Twin Veterans. Arch Neurol, 52:763-771.
4. BRETELER MMB, CLAUS JJ, GROBBEE DE, HOFMAN A. (1994). Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. Br Med J, 308:1604-1608.
5. BRETELER MMB, VAN SWIETEN JC, BOTS ML, GROBBE DE, CLAUS JJ, VAN DEN HOUT JHW, VAN HARSKAMP F, TANGHE HLJ, DE JONG PTVM, VAN GUN J, HOFMAN A. (1994). Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology, 44:12461252.
6. BRUN A, ENGLUND E. (1986). A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neural, 19: 253-262.
7. BURKE WJ, CORONADO PG, SCHMITT CA, GILLESPIE KM, CHUNG HD. (1994). Blood pressure regulation in Alzheimer's disease. J Auton Nerv Syst, 48:65-71.
8. CADELO M, INZITARI D, PRACUCCI G, MASCALCHI M. (1991). Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis, 7:345-351.
9. DAHLöF B, LINDHOLM LH, HANSSON L, SCHERSTEN B, EKBOM T, WESTER PO. (1991). Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet, 333:1281-1285.
10. DE REUCK J, CREVITS L, DE COSTER W, SIEBEN G, VANDER HECKEN H. (1980). Pathogenesis of Binswanger's chronic subcortical encephalopathy. Neurology, 30: 920-928.
11. ELIAS MF, ELIAS PK. (1993). Editorial. Hypertension affects neurobehavioral functioning: so what's new? Psychosom Med, 55:44-50.
12. ELIAS MF, BOBBINS MA, SCHULTE NR JR. (1987). Influence of hypertension on intellectual performance. Causation or speculation? In ELIAS JW et MARSCHALL PH (eds). Cardiovascular disease and behavior, pp. 107-149. Hemisphere, Washington DC.
13. ELIAS MF, BOBBINS MA, SCHULTZ NR JR, STREBTEN DHP, ELIAS PK. (1987). Clinical significance of cognitive performance by hypertensive patients. Hypertension, 9:192-197.
14. ELIAS MF, WOLF PA, D'AGOSTINO RB, COBB J, WHITE LR. (1993). Untreated blood pressure level is inversely related to cognitive functioning: The Framingham study. Am J Epidemiol, 138:353-364.
15. ELIAS PK, D'AGOSTINO RB, RLIAS M, WOLF PA. (1995). Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res, 21: 393-417.
16. FALLET-BIANCO C, ROUDIER M, LAMOUR Y, DAVOUS P. (1990). Étude neuropathologique de 50 cas de démence senile. Rev Neurol (Paris), 146:687-696.
17. FARMER ME, WHITE LR, ABBOTT RD, KITTNER SJ, KAPLAN E, WOLZ MM, BRODY JA, WOLF PA. (1987). Blood pressure and cognitive performance: the Framingham study. Am J Epidemiol, 126:1103-1114.
18. FARNETT L, MULROW CD, LINN WD, LUCEY CR, TULEY MR. (1991). The J-curve phenomenon and the treatment of hypertension: Is there a point beyond the treatment of hypertension is dangerous? JAMA, 265:489-495.
19. FERRUCCI L, GURALNIK JM, SALIVE ME, PAHOR M, CORTI MC, BARONI A, HAVLIK RJ (1996). Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc, 44:237-241.
20. FORETTE F, SEUX ML, STAESSEN JA, THUS L, BIRKENHâGER WH, BARBARSKIENE MR, BABEANU S, BOSSINI A, GIL-EXTREMERA B, GIRERD X, LAKS T, LJLOV E, MOISSEYEV V, TUOMILEHTO J, VANHANEN H, WEBSTER J, YODFAT Y, FAGARD R on behalf of the SYST-EUR INVESTIGATORS. (1998). Prevention of dementia in randomised doubleblind placebo-controlled Systolic Hypertension in Europe (SystEur) trial. Lancet, 352:1347-1351.
21. GORELICK PB, NYENHUIS DL, GARRON DC, COCHRAN E. (1996). Is vascular dementia really Alzheimer's disease or mixed dementia? Neuroepidemiology, 15: 286-290.
22. GUO Z, VITANEN M, FRATIGLIONI L, WINBLAD B. (1996). Low blood pressure and dementia in elderly people: the Kungsholmen project. BrMedJ, 3/2:805-808.
23. GUSSEKLOO J, HEEREN TJ, IZAKS GJ, LIGHTHART GJ, ROOIJMANS HGM. (1995). A communitiy based study of the incidence of dementia in subjects aged 85 years and over. J Neurol Neurosurg Psychiatry, 59:507-510.
24. HACHINSKI VC, POTTER P, MERSKEY H. (1987). Leuko-araiosis. Arch Neurol, 44:21-23.
25. HEBERT R, BRAYNE C. (1995). Epidemiology of vascular dementia. Neuroepidemiology, 14: 240-257.
26. HENON H, DURIEU I, LUCAS C, GODEFROY O, PASQUIER F, LEYS D. (1996). Dementia in stroke. Neurology, 47:852-853.
27. HéNON H, PASQUIER F, DURIEU I, GODEFROY O, LUCAS C, LEBERT F, LEYS D. (1997). Pre-existing dementia in stroke patients: base-line frequency, associated factors and outcome. Stroke, 28: 2429-2436.
28. HENON H, PASQUIER F, DURIEU I, PRUVO JP, LEYS D. (1998). Medial temporal lobe atrophy in stoke patients. Relationship with preexisting dementia. J Neural Neurosurg Psychiatry, 65:641-647.
29. HIJDRA A, VERBEETEN B JR, VERHULST JAPM. (1990). Relation of Leukoaraiosis to lesion type in stroke patients. Stroke, 21: 890894.
30. HOFMAN A, OTT A, BRETELER MME, BOTS ML, SLOOTER AJC, VAN HARSKMP F, VAN DUIJN CN, VAN BROECKHOVEN C, GROBBE DE. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet, 349:151-154.
31. INCE PG, MCARTHUR FK, BJERTNESS E, TORVIK A, CANDY JM, EDWARDSON JA. (1995). Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia, 6:162-168.
32. INZITARI D, GIORDANO GP, ANCONA AL, PRACUCCI G, MASCALCHI M, AMADUCCI L. (1990). Leuko-araiosis, intracerebral hemorrhage and arterial hypertension. Stroke, 21:1419-1423.
33. JELLINGER K, DANIELCZYK W, FISCHER P, GABRIEL E. (1990). Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci, 95:239-258.
34. KOKMEN E, WHISNANT JP, O'FALLON WM, CHU CP, BEARD CM. (1996). Dementia after ischémie stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology, 46:154159.
35. LEYS D, SOETAERT G, PETIT H, FAUQUETTE A, PRUVO JP, STEINUNG M. (1990). Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol, 47:524-527.
36. LEYS D, STEINUNG M, PRUVO JP, PETIT H, SCHELTENS Ph, BARKHOF F. (1991). White matter hyperintensities in Alzheimer's disease and normal aging. Arch Neurol, 48:469-470.
37. LEYS D, PRUVO JP, SCHELTENS Ph, RONDEPIERRE Ph, GODEFROY O, LECLERC X, DE REUCK J. (1992). Leuko-araiosis: relationship with the types of focal lesions occurring in acute cerebrovascular disorders. Cerebrovasc Dis, 2:169-176.
38. LEYS D, PASQUIER F, PARNETTI L. (1998). Epidemiology of vascular dementia. Haemostasis, 28:134-150.
39. LEYS D, PASQUIER F. (1999). Prevention of dementia: Syst-Eur trial. Lancet, 353:236-237.
40. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34: 939-944.
41. MRC WORKING PARTY. (1992). Medical Research Council trial of treatment of hypertension in older adults: principal results. Br MedJ, 304:405-412.
42. PASQUIER F, LEBEHT F, PETIT H. (1994). Pseudo progressive dementia and "strategic" infarcts. In LEYS D, SCHELTENS Ph (eds). Vascular dementia, pp. 47-54. ICG Publications. Dordrecht. The Netherlands.
43. PASQUIER F, LEYS D. (1997). Why are stroke patients prone to develop dementia? J Neurol, 244:135-142.
44. PASQUIER F, LEYS D. (1998). Pression artérielle et maladie d'Alzheimer. Rev Neurol (Paris), 154 :743-751.
45. PRINCE MJ. (1995). Vascular risk factors and atherosclerosis as risk factors for cognitive decline and dementia. J Psychosom Res, 39:525-530.
46. PRINCE MJ, BIRD AS, BLIZARD RA, MANN AH. (1996). Is the cognitive function of older patients affected by antihypertension treatment? Results from 54 months of the medical research council's treatment trial of hypertension in older adults. Br Med J, 312: 801-805.
47. ROMAN GC, TATEMICHI TK, ERKINJUNTTI T, CUMMINGS JL, MASDEU JC, GARCIA JH, AMADUCCI L, ORGOGOZO JM, BRUN A, HOFMAN A, MOODY DM, O'BRIEN MD, YAMAGUCHI T, GRAFMAN J, DRAYER BP,
48. BENNETT DA, FISHER M, OGATA J, KOKMEN E, BERME JOF, WOLF PA, GORELICK PB, BICK KL, PAJEAU AK, BELL MA, DECARLI C, CULEBRAS A, KORCZYN AD, BOGOUSSLAVSKY J, HARTMANN A, SCHEINBERG P. (1993). Vascular dementia: diagnostic criteria for research studies. Neurology, 43: 250-260.
49. SANDERCOCK PAG, WARLOW CP, JONES LN, STARKEY IR. (1989). Predisposing factors for cerebral infarction: the Oxfordshire community stroke project? Br Med J, 298: 75-79.
50. SCHEINBERG P. (1988). Dementia due to vascular disease: a multifactorial disorder. Stroke, 19:1782-1788.
51. SCHELTENS P, BARKHOF F, V/ALK J, ALGRA PR, VAN DER HOOP R, NAUTA J, WOLTERS EC. (1992). White matter lesions on Magnetic Resonance imaging in Alzheimer's disease: evidence for heterogeneity. Brain, 115:735-743.
52. SCHELTENS P, VERMERSCH P, LEYS D. (1993). Hétérogénéité de la maladie d'Alzheimer. Rev Neurol (Paris), 149:14-25.
53. SCHERR PA, HEBERT LE, SMITH LA, EVANS DA. (1991). Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol, 734:1303-1315.
54. SCHMIDT R, FAZEKAS F, OFFENBACHER H, DUSEK T, ZACH E, REINHART B, GRIESHOFER P, FREIDL W, EBER B, SCHUMACHER M, KOCH M, LECHNER H. (1993). Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology, 43:2490-2494.
55. SCHMIDT R, FAZEKAS F, OFFENBACHER H, LYTWYN H, BLEMATL B, NIEDERKORN K, HORNER S, PAYER F, FREIDL W. (1991). Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol, 48:417-420.
56. SHEP COOPERATIVE RESEARCH GROUP. (1991). Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA, 265: 3255-3264.
57. SHIMANO H, ISHIBASHI S, MURASE T. (1989). Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis, 79:257-260.
58. SKOOG I, NILSSEN L, PALMERTZ B, ANDREASSON LA, SVANBORG A. (1993). A population-based study of dementia in 85-year-olds. NEngl J Med, 328:153-158.
59. SKOOG I, LERNFELT B, LANDAHL S, PALMERTZ B, ANDREASSON LA, NILSSON L, PERSSON G, ODEN A, SVANBORG A. (1996). 15-year longitudinal study of blood pressure and dementia. Lancet, 347: 1141-1145.
60. SNOWDON DA, GREINER LH, MORTIMER JA, RILEY KP, GREINER PA, MARKESBERY WR. (1997). Brain infarction and the clinical expression of Alzheimer disease. The nun study. JAMA, 277:813-817.
61. STAESSEN JA, FAGARD R, THUS L, CELIS H, ARABIDZE GG, BIRKENHAGER WH, BULPITT CJ, DE LEEUW PW, DOLLERY CT, FLETCHER AE, FORETTE F, LEONETTI G, NACHêV C, O'BRIEN ET, ROSENFELD J, RODICIO JL, TUOMILEHTO J, ZANCHETTi A. (1997). Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet, 350: 757-764.
62. STEINGART A, HACHINSKI VC, LAU C, Fox AJ, DIAZ F, CAPE R, LEE D, INZITARI D, MERSKEY H. (1987a). Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (Leuko-araiosis). Arch Neurol, 44: 32-35.
63. STEINGART A, HACHINSKI VC, LAU C, Fox AJ, Fox H, LEE D, INZITARI D, MERSKEY H. (1987b). Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch Neurol, 44: 36-39.
64. STRANDGAARD S, PAULSON OB. (1994). Cerebrovascular consequences of hypertension. Lancet, 344: 519-521.
65. TATEMICHI TK, FOULKES MA, MOHR JP, HEWITT JR, HIER DB, PRICE TR, WOLFPA. (1990). Dementia in stroke survivors in the stroke data bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke, 21: 858-866.
66. TATEMICHI TK, PAIK M, BAGIELLA E, DESMOND DW, STERN Y, SANO M, HAUSER WA, MAYEUX R. (1994). Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology, 44:1885-1891.
67. VAN DUIJN CM. (1996). Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry, 60:478-488.
68. VAN SWIETEN JC, GEYSKES GG, DERIX MMA, PEECK BM, RAMOS LMP, VAN LATUM JC, VAN GUN J. (1991). Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol, 30: 825-830.
69. VICTOROFF J, MACK WJ, LYNESS SC, CHUI HC. (1995). Multicenter clinicopathological correlation in dementia. Am J Psychiatry, 152:1476-1484.
70. WALDSTEIN SR, RYAN CM, MANUCK SB, PARKINSON DK, BROMET EG. (1991). Learning and memory function in men with untreated blood pressure elevation. J Consult Clin Psychol, 59: 513-517.
71. WiLKiE FL, EISDORFER C. (1981). Hypertension and tests of memory. In: ELLIAS MF, STREETEN DHP (eds). Hypertension and cognitive processes pp: 71-82. Mount Desert, M.E. Beech Hill.
72. WOLF PA, KANNEL WB, McGEE DL. (1986). Prevention of ischemic stroke: risk factors. Irr. BARNETT HUM, STEIN BM, MOHR JP, YATSU FM (eds). Stroke, pathophysiology, diagnosis and management pp: 967-988. Churchill Livingstone. New york, Edinburg, London, Melbourne.
73. YLIKOSKI R, YLIKOSKI A, ERKINJUNTTI T, SULKAVA R, RAININKO R, TILVIS R. (1993). White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neural, 50:818-824.
74. ZUBER M, MAS JL. (1993). Epidemiologie des accidents vasculaires cérébraux. In : BOGOUSSLAVSKY J, BOUSSER MG, MAS JL. Accidents vasculaires cérébraux pp : 13-26. Doin Éditeurs. Paris.